Results 91 to 100 of about 24,617 (185)

ESBL- A therapeutic challenge

open access: yesBangladesh Journal of Medical Microbiology, 2010
Bangladesh J Med Microbiol 2010; 03 (02): 1 ...
openaire   +2 more sources

Fungal Antimicrobial Resistance: Mechanisms, Drivers, and Global Clinical Burden

open access: yesChemFoodChem, Volume 2, Issue 3, September 2026.
ABSTRACT Fungal antimicrobial resistance (AMR) is a growing concern for world health caused by an increase in multidrug‐resistant infections, an increase in environmental reservoirs, and the ineffectiveness of current antifungal treatments. Fungal infections continue to be largely excluded from AMR initiatives while causing over 1.6 million deaths ...
Bikash Baral
wiley   +1 more source

ESBL-Positive Enterobacteria Isolates in Drinking Water

open access: yesEmerging Infectious Diseases, 2012
To the Editor: Extended-spectrum β-lactamase (ESBL)–producing members of the family Enterobacteriaceae (enterobacteria) are a worldwide problem (1), but little data are available from central Africa (2). In recent years, ESBL-producing Enterobacteriaceae isolates have shifted from the hospital to the community and the environment (1).
De Boeck, H.   +6 more
openaire   +4 more sources

ESBL termelő törzsek intesztinális hordozásának alakulása az Egyetem Klinikáin

open access: yes, 2018
Az ESBL termelő bélbaktériumok kórházi fertőzések jelentős okozói, multirezisztenciájuk miatt jelentős terápiás problémát és carbapenem fogyasztásnak a fokozódását okozzák.
Daruka, Dóra
core  

Dose Selection for Ceftibuten Combined with Avibactam Tomilopil, a Potential Oral Alternative to Carbapenems for Patients with Complicated Urinary Tract Infections

open access: yesThe Journal of Clinical Pharmacology, Volume 66, Issue 9, September 2026.
Abstract There are currently no oral treatment options for infections caused by extended spectrum β‑lactamase‐producing Enterobacterales. Avibactam tomilopil, a novel oral prodrug of avibactam, is being developed in combination with the oral cephalosporin, ceftibuten, as a potential treatment for patients with complicated urinary tract infections ...
Siddhee A. Sahasrabudhe   +13 more
wiley   +1 more source

ESBL termelő baktériumok ceftazidim/avibactam érzékenységének in vitro vizsgálata

open access: yes, 2015
ESBL termelő törzsek érzékenységének ceftazidim/avibactam kombináció és különböző carbapenemek (imipenem, meropenem, doripenem) in vitro vizsgálata. A célkitűzésem az volt, hogy az in vitro eredmények alapján a ceftazidim/avibactam kombináció megfelelő ...
Incze, Boglárka
core  

Real‐Life Study on Gilteritinib‐Related Infections (GilteRInf): An Italian SEIFEM Study

open access: yes
American Journal of Hematology, Volume 101, Issue 10, Page 2672-2676, October 2026.
Elisa Buzzatti   +25 more
wiley   +1 more source

Detecting Antibiotic Resistance in Strains of Selected Gram‐Negative Bacterial Species Using Raman Spectroscopy

open access: yesJournal of Raman Spectroscopy, Volume 57, Issue 9, Page 1554-1564, September 2026.
Raman spectroscopy successfully identified antibiotic‐resistant Gram‐negative strains. Resistant strains of four bacterial species were discriminated from sensitive ones with 99.1% accuracy using PLS regression. The method allows for rapid, label‐free detection of antibiotic resistance.
Fernanda Sant Ana de Siqueira e Oliveira   +3 more
wiley   +1 more source

Living with ESBLs [PDF]

open access: yesClinical Microbiology and Infection, 2007
Cornaglia, G.   +2 more
openaire   +1 more source

Comparison of virulence factors between ESBL and non-ESBL producing Klebsiella pneumoniae isolates

open access: yesIranian Journal of Microbiology
Background and Objectives: Klebsiella pneumoniae is an opportunistic pathogen responsible for causing nosocomial and community-acquired infections. Its pathogenicity is associated with a variety of virulence factors and antibiotic resistance. The aim of the present study was to compare virulence attributes between ESBL and non-ESBL producing isolates.
Hamed Hatami Mirbag   +3 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy